Close Menu
  • Finance
  • Crypto
  • Investments
  • Stock Market
  • News
  • Business
  • Technology
    • Technology
    • AI
  • Lifestyle
    • Lifestyle
    • Marketing
    • Travel & Tourism
    • Work & Careers
    • Health
    • Property
Categories
  • AI
  • Appointments
  • Awards
  • best
  • Blog
  • Book Publishing
  • Business
  • Construction
  • Crypto
  • Energy
  • Events
  • Fashion
  • Featured
  • Finance
  • Government
  • Health
  • Health & Fitness
  • Investments
  • Lifestyle
  • Marketing
  • Medical
  • Money
  • News
  • Property
  • Stock Markets
  • Technology
  • Travel & Tourism
  • Uncategorized
  • Wallet
  • Work & Careers
X (Twitter)
  • About
  • Authors
  • Contact Us
  • Submit story
X (Twitter)
Financial Investor 24Financial Investor 24
  • Finance
  • Crypto
  • Investments
  • Stock Market
  • News
  • Business
  • Technology
    • Technology
    • AI
  • Lifestyle
    • Lifestyle
    • Marketing
    • Travel & Tourism
    • Work & Careers
    • Health
    • Property
Financial Investor 24Financial Investor 24
Home » FundedNext Labs Experiment Charges Traders to Test Its Own New Rules
FundedNext Labs experiment
Finance

FundedNext Labs Experiment Charges Traders to Test Its Own New Rules

Edward SeftonBy Edward SeftonJuly 28, 2026No Comments4 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email Copy Link

The FundedNext Labs experiment asks paying traders to do something unusual: hand over $99.99 to trial a challenge whose rules the firm has not yet decided to keep. FundedNext, the UAE-based prop firm, launched Labs as a separate testing track where experimental account structures run on a small, paying pool of real participants before any decision is made to roll them out more widely.

FundedNext Labs Experiment: What FNL01 Actually Changes

The first release, FNL01, is a one-step simulated challenge on a $50,000 account. Its headline feature is the removal of the daily loss limit, replaced by a $2,000 end-of-day trailing maximum loss. A 6% profit target applies, meaning traders need to bank $3,000 to pass.

Removing the daily cap does not make the account straightforwardly easier. Traders still face elimination if a single session burns through the $2,000 trailing drawdown (the maximum amount the account can fall from its peak before it is closed). What changes is the measurement window: risk is tracked across the whole account rather than reset against a separate intraday ceiling each day.

A 40% consistency rule applies during the challenge phase, meaning no single day’s profit can represent more than 40% of total profits. That rule falls away once a trader passes and moves to funded status, where the profit split sits at 80%. There is no time limit, and news trading, weekend holding, and overnight positions are all permitted.

The account does not run indefinitely after funding. FundedNext caps each FNL01 account at five payouts before it closes. To reach the first payout, traders need at least five benchmark trading days each generating $200 or more, plus $500 in total profit. The minimum withdrawal is $250, and each payout is capped at 50% of accumulated profit up to $2,000 per withdrawal. Once the first payout clears, the maximum loss limit locks at $50,100.

FundedNext also operates its own brokerage, FNmarkets. The Labs track is separate from that operation and sits alongside the firm’s existing CFD product range.

A Market Moving Away from Restrictive Rules

FundedNext is not the only firm pulling back on the mechanics traders dislike most. E8 Markets launched E8 Zero in July 2026, a one-step account that removes both the consistency rule and the trailing drawdown. Pipcy, which went live in May 2026, runs a challenge with a single overall loss cap and no daily drawdown at all.

The direction of travel is consistent with what traders report wanting. In a PipFarm survey shared with FinanceMagnates.com, 54% of respondents named trailing drawdown as the feature they most wanted to avoid, and 53% said the same of consistency rules. FundedHive’s chief executive went further, describing the consistency rule as ‘a payout trap’ and arguing that failed firms were built as marketing operations rather than risk businesses.

Against that backdrop, the FundedNext Labs experiment is less a break from the firm’s existing range than a repackaging of it. FundedNext already offers accounts with no daily loss limit through its Instant products, so FNL01 is essentially the same condition wrapped in a cheap, one-step CFD format sold in limited batches.

The Labs structure does give the firm a practical advantage: it can trial pricing, drawdown mechanics, and payout terms on live accounts without altering the rules that existing customers already trade under. Changing terms on active accounts has caused problems elsewhere. FundingTicks, an affiliate of FundingPips, drew heavy trader backlash after a retroactive rule change.

The US market adds a layer of complexity. FundedNext returned to US CFD clients after stepping back during the 2024 crackdown on MetaQuotes, which barred MT4 and MT5 from American users. US clients now trade on Match-Trader or cTrader, according to the FundedNext Help Centre. That is a constrained slice of the firm’s overall base: FundedNext’s own platform data shows MT5 accounts for 64.93% of its traders globally, while Match-Trader serves just 6.87%. US clients are also excluded from the 15% challenge reward available to traders elsewhere who grow their account by 10%.

The broader regulatory picture gives prop firms a reason to be cautious. US firms are operating closer to the Commodity Futures Trading Commission (CFTC) perimeter as the sector absorbs the fallout from a series of collapses linked to opaque drawdown rules. Whether FNL01’s stripped-back structure becomes a permanent product depends on what FundedNext learns from the traders paying to be its test group.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Avatar photo
Edward Sefton

Edward Sefton spent eighteen years in asset management before he started writing about markets. He began on the graduate scheme at a large UK fund house, moved to the multi-asset desk, and spent the bulk of his career running balanced mandates for pension schemes and charities. He left after the third reorganisation in five years and started filing copy because the industry needed fewer product launches and more honest commentary. He writes about fund performance, asset allocation, pensions, and the gap between what the marketing deck says and what the factsheet shows. He has sat through enough quarterly reviews to know when a fund manager is explaining alpha and when they are explaining luck. Edward lives in Hampshire. He reads the IA sector averages before breakfast and considers most investment commentary to be hindsight with a Bloomberg terminal.

Related Posts

Union Jack Oil Offer Timetable Tightens as Jarvis and Sutton Harbour Also Come Into Focus

September 16, 2026

Tulu Kapi Underground Mine PEA Delivers a 220% IRR, But Development Is Now on Hold

September 16, 2026

Thruvision Canadian Government Contract Lifts Shares Over 30%, But Does the Valuation Stack Up?

September 16, 2026
Search
Finance

Union Jack Oil Offer Timetable Tightens as Jarvis and Sutton Harbour Also Come Into Focus

By Edward SeftonSeptember 16, 2026

The Union Jack Oil offer from Reabold Resources has moved into a critical phase, with…

UK Investment Banking Push: ÜNLÜ & Co’s London Arm Becomes UNLU Merchant Bank

September 16, 2026

Tulu Kapi Underground Mine PEA Delivers a 220% IRR, But Development Is Now on Hold

September 16, 2026

Thruvision Canadian Government Contract Lifts Shares Over 30%, But Does the Valuation Stack Up?

September 16, 2026

Retail Traders Can Now Access CME Single-Stock Futures Through TradeStation

September 15, 2026

Pelican Copy Trading Licence Marks a South African First

September 15, 2026
© 2026 Financial Investor 24
  • Home
  • About
  • Contact Us
  • Submit story
  • Authors
  • Advertising Policy
  • Correction Policy
  • Privacy Policy
  • Terms
  • Cookies

Type above and press Enter to search. Press Esc to cancel.